Search Results - "PANDITHARATNA, Eshini"
-
1
Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
Published in Scientific reports (03-03-2021)“…Diffuse midline glioma (DMG) is a highly morbid pediatric brain tumor. Up to 80% of DMGs harbor mutations in histone H3-encoding genes, associated with poor…”
Get full text
Journal Article -
2
Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy
Published in Clinical cancer research (01-12-2018)“…Pediatric diffuse midline glioma (DMG) are highly malignant tumors with poor clinical outcomes. Over 70% of patients with DMG harbor the histone 3 p.K27M…”
Get full text
Journal Article -
3
Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
Published in Nature communications (06-04-2016)“…Diffuse Intrinsic Pontine Gliomas (DIPGs) are deadly paediatric brain tumours where needle biopsies help guide diagnosis and targeted therapies. To address…”
Get full text
Journal Article -
4
Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas
Published in Scientific reports (02-07-2020)“…Children diagnosed with brain tumors have the lowest overall survival of all pediatric cancers. Recent molecular studies have resulted in the discovery of…”
Get full text
Journal Article -
5
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous system
Published in JCI insight (10-10-2022)“…Collateral lethality occurs when loss of a gene/protein renders cancer cells dependent on its remaining paralog. Combining genome-scale CRISPR/Cas9…”
Get full text
Journal Article -
6
Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings
Published in Frontiers in oncology (14-01-2020)“…Anaplastic astrocytomas are aggressive glial cancers that present poor prognosis and high recurrence. Heterozygous IDH1 R132H mutations are common in…”
Get full text
Journal Article -
7
The growing role of epigenetics in childhood cancers
Published in Current opinion in pediatrics (01-02-2020)“…Altered epigenetics is central to oncogenesis in many pediatric cancers. Aberrant epigenetic states are induced by mutations in histones or epigenetic…”
Get full text
Journal Article -
8
DIPG-26. Targeted Protein Degradation of LSD1 synergizes with HDAC inhibitors in Diffuse Intrinsic Pontine Glioma
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Diffuse intrinsic pontine glioma (DIPG) remains one of the most lethal brain tumors in all of childhood with no effective treatments besides radiation, which…”
Get full text
Journal Article -
9
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium
Published in International journal of cancer (01-10-2019)“…This clinical trial evaluated whether whole exome sequencing (WES) and RNA sequencing (RNAseq) of paired normal and tumor tissues could be incorporated into a…”
Get full text
Journal Article -
10
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
Published in Nature genetics (01-12-2022)“…Histone 3 lysine27-to-methionine (H3-K27M) mutations most frequently occur in diffuse midline gliomas (DMGs) of the childhood pons but are also increasingly…”
Get full text
Journal Article -
11
PDTM-07. DETECTION OF IDH1 R132H MOSAICISM IN ANAPLASTIC ASTROCYTOMA PATIENTS
Published in Neuro-oncology (Charlottesville, Va.) (05-11-2018)“…Abstract Anaplastic astrocytomas are aggressive cancers of glial cells that present poor prognosis and high recurrence. Heterozygous mutations in IDH1 and IDH2…”
Get full text
Journal Article -
12
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas
Published in Neuro-oncology (Charlottesville, Va.) (01-09-2022)“…Abstract Background Pediatric diffuse midline gliomas (DMGs) are incurable childhood cancers. The imipridone ONC201 has shown early clinical efficacy in a…”
Get full text
Journal Article -
13
DDEL-04. Pharmacokinetic/Pharmacodynamic analysis of the DNA methyltransferase inhibitor 5-azacytidine shows adequate brain tissue penetration with intravenous administration in a DIPG mouse patient-derived xenograft model
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…One of the biggest obstacles in developing effective therapies for CNS tumors is drug delivery due to the enigmatic challenge of penetrating the blood-brain…”
Get full text
Journal Article -
14
GENE-20. MULTI-GENE MUTATION PROFILING OF PEDIATRIC MIDLINE GLIOMAS USING PATIENT LIQUID BIOPSY
Published in Neuro-oncology (Charlottesville, Va.) (23-04-2019)“…Abstract INTRODUCTION: Molecular profiling of the tumor genome is critical for diagnosis and clinical management of CNS tumors. In the case of pediatric…”
Get full text
Journal Article -
15
Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report
Published in Oncotarget (12-05-2023)Get full text
Journal Article -
16
PDTM-42. CROSS-PLATFORM PROFILING OF ctDNA USING ddPCR: STANDARDIZATION OF THE LIQUID BIOPSY FOR PEDIATRIC DIFFUSE MIDLINE GLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (11-11-2019)“…Abstract INTRODUCTION Pediatric diffuse midline glioma (DMG) with histone H3 mutations (80%), are highly morbid tumors with poor response to therapy. We…”
Get full text
Journal Article -
17
DIPG-31. TUMOR SURVEILLANCE USING LIQUID BIOME IN PEDIATRIC HIGH GRADE GLIOMAS
Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)“…Abstract Immunotherapy is currently being used to treat pediatric brain cancer, though its efficacy in treating patients with diffuse intrinsic pontine glioma…”
Get full text
Journal Article -
18
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Published in Cancer discovery (02-12-2022)“…Diffuse midline gliomas are uniformly fatal pediatric central nervous system cancers that are refractory to standard-of-care therapeutic modalities. The…”
Get more information
Journal Article -
19
A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)
Published in Clinical cancer research (01-12-2013)“…Imetelstat is a covalently-lipidated 13-mer thiophosphoramidate oligonucleotide that acts as a potent specific inhibitor of telomerase. It binds with high…”
Get full text
Journal Article -
20
Abstract 810: Establishing patient derived preclinical in vitro and in vivo models of pediatric brain cancers
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…The recent surge in understanding genomic aberrations of some of the deadliest childhood brain cancers has highlighted the need for robust preclinical models…”
Get full text
Journal Article